<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04218942</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL19_0395</org_study_id>
    <nct_id>NCT04218942</nct_id>
  </id_info>
  <brief_title>Rocamed Urethral Device (RUD) and Urinary Retention in Males</brief_title>
  <acronym>RUD</acronym>
  <official_title>Interest of Rocamed Urethral Device for Treatment of Acute or Chronic Urinary Retention in Males</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective non randomized study of the feasibility of the insertion of Rocamed urethral&#xD;
      device by hand manipulation, i.e., without use of cystoscopy, sonography or fluoroscopy.&#xD;
      Patients with an acute urinary retention treated by Foley catheterization in the Emergency&#xD;
      department have a few days later a trial of Foley removal in the ambulatory unit of the&#xD;
      Urology department. In case of failure of the Foley removal trial, i.e., recurrence of&#xD;
      urinary retention, patients will be proposed either the insertion of a new Foley or insertion&#xD;
      of the urethral device. After signature of an informed consent, insertion of the urethral&#xD;
      device will be performed after instillation in the urethra of a local anesthetic gel. Device&#xD;
      insertion success rate and complications will be studied. The device will be left in place&#xD;
      for one month. Tolerance and complications during the month with the device in place will be&#xD;
      studied. At one month the device will be removed: the ease of retrieval of the device and&#xD;
      complications will be studied. Patient and doctor satisfaction with the urethral device will&#xD;
      be compared to patient and doctor satisfaction with the Foley.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 12, 2020</start_date>
  <completion_date type="Actual">June 29, 2021</completion_date>
  <primary_completion_date type="Actual">June 29, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients in whom the device will be inserted only by hand manipulation</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient tolerance during device insertion: analogic visual scale 0-10 (0 : no pain / 10 : worst pain imaginable)</measure>
    <time_frame>Day 0 (Day of device insertion)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient tolerance during one month: analogic visual scale 0-10 (0 : excellent tolerance / 10 : intolerable)</measure>
    <time_frame>1 Month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flowmetry with device in place ml/sec</measure>
    <time_frame>Day 0 (Day of device insertion)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient tolerance during retrieval of the device : analogic visual scale 0-10 (0 : no pain / 10 : worst pain imaginable)</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Urinary Retention</condition>
  <arm_group>
    <arm_group_label>Prospective non randomised feasibility study</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Exime is the name of the single use temporary prostatic stent used instead of the Foley catheter</intervention_name>
    <description>Insertion after instillation of a local lubricant anesthetic gel in the urethra like for Foley insertion. Calibration of the urethral meatus with a 22F Bougie. Insertion of the Bougie until abutment against the posterior wall of the bulbous urethra just below the striated sphincter. Note depth of abutment on the scale of the Bougie. Retrieve the Bougie and glide the device to the same depth until abutment against the posterior wall of the bulbous urethra. At this stage the stent is correctly positioned. Stent release: unlock the Luer connection between pusher tube and stylet . Retrieve pusher tube, stylet and flattener tube.&#xD;
Control of correct positioning: ask patient to stand up to verify the absence of any urine leak. Ask patient to void immediately to control clear urine output.</description>
    <arm_group_label>Prospective non randomised feasibility study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male &gt; 18 years old&#xD;
&#xD;
          -  Acute retention treated by Foley&#xD;
&#xD;
          -  Failure of Foley removal trial&#xD;
&#xD;
          -  Clear urine&#xD;
&#xD;
          -  No urinary infection&#xD;
&#xD;
          -  Efficient striated sphincter&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Urethral stenosis&#xD;
&#xD;
          -  Hematuria macroscopic&#xD;
&#xD;
          -  Urinary infection&#xD;
&#xD;
          -  Anticoagulant treatment&#xD;
&#xD;
          -  Lidocaine allergy&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Service d'Urologie Hôpital Lyon Sud, Hospices Civils de Lyon</name>
      <address>
        <city>Pierre-Bénite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 3, 2020</study_first_submitted>
  <study_first_submitted_qc>January 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2020</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Urethral Device</keyword>
  <keyword>Foley catheterization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Retention</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

